Vimarsana
Biggest News Aggregation in the World

Page 39 - Translational Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Translational Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Translational Sciences Today - Breaking & Trending Today

ImmunoBiochem Announces Multi-Target License and Option Agreement with ImmunoGen to Develop Next-Generation Antibody-Drug Conjugates - Vimarsana News

ImmunoBiochem Announces Multi-Target License and Option Agreement with ImmunoGen to Develop Next-Generation Antibody-Drug Conjugates

/PRNewswire/ - ImmunoBiochem Corporation, a privately-held biopharmaceutical company focused on the discovery of unique tumor targets and development of novel...

5 takeaways from POLITICO's Next Generation of Health Care Therapies Event - Vimarsana News

5 takeaways from POLITICO's Next Generation of Health Care Therapies Event

Gene therapy advocates say the treatments can cure rare diseases more quickly if government helps.

Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System | Coagulation Disorders | JAMA - Vimarsana News

Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System | Coagulation Disorders | JAMA

This study examines the incidence of and risk factors for venous and arterial thrombosis in patients hospitalized with COVID-19 in 4 New York City hospitals.

The kidney, in all its complexity, is captured in a new atlas - Vimarsana News

The kidney, in all its complexity, is captured in a new atlas

Years in the making, the atlas identifies 1.2 million “injury neighborhoods,” which could help uncover the causes of kidney disease.

Lundquist Institute Investigator Dr. Virender Rehan and Advent Therapeutics Awarded $3 Million ... - Vimarsana News

Lundquist Institute Investigator Dr. Virender Rehan and Advent Therapeutics Awarded $3 Million ...

Los Angeles, California, July 18, 2023 (GLOBE NEWSWIRE) -- The Lundquist Institute and Advent Therapeutics have announced a landmark collaboration that has resulted in a significant $3 million Small Business